SRF, a leading chemical manufacturer, has announced its consolidated financial results for the second quarter and half-year ending 30 September, 2025.

The company has entered a strategic collaboration with The Chemours Company, focusing on fluoropolymers and fluoroelastomers, expected to drive future growth. The Specialty Chemicals Business reported increased product volumes and positive momentum from new product introductions. Operational efficiency improvements in the Fluorochemicals and Specialty Chemicals segments enhanced margin performance. The Performance Films and Foil Business achieved margin growth in its value-added products, maintaining its leadership in BOPET film exports from India.

Capital expenditure for the fluoropolymer project has been revised upward from Rs 595 crore to Rs 745 crore, with the final phase expected to complete by December 2026.